A prospective analysis of the effect of statins on postprandial serum triglyceride level

A prospective analysis of the effect of statins on postprandial serum triglyceride level - Effect of statins on postprandial serum triglyceride level

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004156

Enrollment

300

Registered

2010-09-06

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

We administer rosuvastatin 5mg or pisuvastain 2mg daily to patients with dyslipidemia that could not be improved with 8-week dietary practice.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligible patients are those with dyslipidemia based on the diagnostic guideline of dyslipidemia of Japan Atherosclerosis Society, and that could not be improved with 8-week dietary practice.

Exclusion criteria

Exclusion criteria: Patients with thyroid disorders, nephrotic syndrome, cirrhosis, hemodialysis, and who have taken drugs for dyslipidemia.

Design outcomes

Primary

Measure	Time frame
Fasting and postprandial level of serum HDL, LDL, and triglyceride 4 to 8 weeks after statin administration.	—

Countries

Japan

Contacts

Public ContactYoshiharu Fujimori

Suwa Central Hospital Department of Cardiology

fujimori.yoshiharu@gmail.com0266-72-1000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026